Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Cell Lung Cancer × apatorsen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 2 Squamous Cell Lung Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neuronopathy, Distal Hereditary Motor, Type IIB 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 2 Docetaxel 2 Carboplatin 2 iniparib 1 bleomycin A6 1 apatorsen 1 Pemetrexed 1 Injections 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02423590 2017-08-22

Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers

Queen Mary University of London

Phase 2 Unknown

Squamous Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡